Steady, sustainable weight loss without the drastic cravings or intense hunger that often comes with traditional dieting methods
In type 2 diabetes , the body either becomes resistant to insulin, doesnt produce enough insulin, or both, making blood sugar control difficult
Wegovy (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to: reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
The Endocrine Society's 2024 guidelines on pharmacological obesity management recommend baseline hepatic and renal function assessment before initiating any incretin-based therapy [4]
In clinical trials, Semaglutide resulted in an average weight loss of 15% over 68 weeks, while Tirzepatide achieved up to 20% over 72 weeks, both paired with diet and exercise
Outra medicao que estimula tanto o receptor de GLP-1 quanto o GIP a Tirzepatida (Princpio ativo do Mounjaro), sendo atualmente a medicao com a maior taxa de perda de peso nos estudos clnicos fase III